Para continuar, acessesua conta trace-id: 76a1d215-a52a-4c38-8079-7c3dc2cdd109 Usamos cookies para melhorar sua experincia no Mercado Livre
The proposal draws a billing line, not a medical one
In 2003, there seemed to be good reasons to leave weight-loss drugs out of the benefit, write Inmaculada Hernandez of the University of California, San Diego, and coauthors in their September 2023 editorial in the Journal of General Internal Medicine, Medicare Part D Coverage of Anti-obesity Medications: a Call for Forward-Looking Policy Reform. When members of Congress worked on the Part D benefit, the drugs available on the market were known to have limited effectiveness and unpleasant side effects
Error one: A researcher calculates 250mcg 2.5mg/mL = 100mL
Eating less often means getting fewer healthy fats
Glutathione might interfere with chemotherapy medications